Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: Results from the randomized prospective phase III FFCD-0307 trial
New research shared in MD Linx looks at prognostic factors in patients with advanced gastric cancer treated with second-line chemotherapy.
Clinicopathological significance of RCAN2 production in gastric carcinoma
Researchers examined calcineurin 2 (RCAN2) regulators and expression patters, finding RCAN2 is correlated with tumor progression and an independent prognostic classifier for... Read More
Third line treatment of advanced oesophagogastric cancer: A critical review of current evidence and evolving trends
A review of evolving trends in third line treatment of advanced gastric cancer shows sequential treatment approaches benefit a growing minority of... Read More
ENA NEWS: Patients with cancers of the gullet, stomach and bowel respond well to new anti-HER2 drug
New research published in European Cancer finds gastric cancer patients respond well to a new anti-HER2 drug, which binds to two distinct... Read More
Dr. Iqbal on Second- and Third-Line Therapies in Gastric Cancer
Dr. Syma Iqbal, Keck School of Medicine at University of Southern California, discusses second- and third-line therapies in gastric cancer via OncLive.
Implications of FGF 2 Amplification for GI Cancer Treatment
Watch this new video on the implications of fibroblast growth factor (FGF) 2 amplification for GI Cancer Treatment.
FDA Grants Priority Review to TAS-102 for Gastric/GEJ Cancer
Shared in OncLive, the FDA has granted priority review to a supplemental new drug application for TAS-102 (trifluridine/tipiracil; Lonsurf) for use in... Read More
Helicobacter pylori status and risks of metachronous recurrence after endoscopic resection of early gastric cancer: a systematic review and meta-analysis
A meta-analysis investigates the relationship between H. pylori status (H. pylori negative, H. pylori eradication and H. pylori persistence) and the development... Read More
Women more prone to selected oesophagogastric cancer chemotherapy side-effects
New research presented at ESMO investigates whether men and women should be treated differently in cancer care, finding women are more prone... Read More
Molecular features and translational outlook for Epstein–Barr virus-associated gastric cancer
Published in the Future Science Group, new research projects molecular features and translational outlook for Epstein–Barr virus-associated gastric cancer.
